Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding

This publication has 16 references indexed in Scilit:

• Discovery of L-791,943: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor
  Bioorganic & Medicinal Chemistry Letters, 2002
• The next generation of PDE4 inhibitors
  Current Opinion in Chemical Biology, 2001
• Genomic organization of the human phosphodiesterase PDE11A gene
  European Journal of Biochemistry, 2001
• Idiosyncratic drug reactions: the reactive metabolite syndromes
  The Lancet, 2000
• ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic
  Pulmonary Pharmacology & Therapeutics, 1999
• Expired Nitric Oxide and Airway Obstruction in Asthma Patients with an Acute Exacerbation
  American Journal of Respiratory and Critical Care Medicine, 1999
• Phosphodiesterase Isozymes
  American Journal of Respiratory and Critical Care Medicine, 1998
• Biotransformation of the antidepressant D,L-rolipram. II. Metabolite patterns in man, rat, rabbit, rhesus and cynomolgus monkey
  Xenobiotica, 1993
• Covalent and Noncovalent Interactions in Acute Lethal Cell Injury Caused by Chemicals
  Annual Review of Pharmacology and Toxicology, 1990
• Cyclic AMP-dependent Regulation of Lipid Mediators in White Cells: A Unifying Concept for Explaining the Efficacy of Theophylline in Asthma
  American Review of Respiratory Disease, 1987